杂志简称：j interv card electr
中文译名：《心脏介入电生理学杂志》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：14.60%
投稿方向：医学、cardiac & cardiovascular systems 心脏和心血管系统
SCI/E期刊基本信息
出版周期：年9期 地区：荷兰
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1383-875X；EISSN1572-8595
杂志语言：英语
出版国家：荷兰
杂志官网 联系方式
出版地址：SPRINGER,VAN GODEWIJCKSTRAAT 30,DORDRECHT,NETHERLANDS,3311 GZ
杂志邮箱：
投稿网址：https://www.editorialmanager.com/jice/
杂志官方网址：https://www.springer.com/journal/10840
出版商网址：http://www.springeronline.com
杂志投稿要求
期刊相关咨询邮箱【杂志社官方网站信息】
Contact the journal
Submission-related enquiries
Queries about submission issues, peer review process, or the status of your manuscript should be sent to Cindylyn Arjona (cindylyn.arjona@springer.com).
Production-related enquiries
Queries about accepted manuscripts in production or post-publication corrections should be sent to Maria Cathelyn Pis-an (MariaCathelyn.Pis-an@springer.com).
Rights and Permissions enquiries
For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.
Publication-related enquiries
Queries related to journal publishing should be sent to Melissa Ramondetta (melissa.ramondetta@springer.com).
投稿须知【杂志社官方网站信息】
Journal of Interventional Cardiac Electrophysiology
Submission guidelines
Instructions for Authors
Types of Papers
Original research, Systematic Review, State of the Art Articles, Clinical Trial in Focus, Technical Report, Editorial Commentary, News and Views, Letter to the Editor, Multicenter Clinical Trials.
Although original research is the primary focus of the Journal, submission of other formats that inform the clinician and investigator is encouraged. All formats except News & Views require abstracts, undergo peer-review and require full disclosure of potential conflicts of interest. All Featured Articles must conform to the manuscript style of original articles as noted above.
Systematic Review
The purpose of this format is to examine all information relevant to a well-circumscribed subject and provide conclusions based on the analysis. The review should be structured so the reader can readily identify the important elements. A structured abstract should be provided which summarizes the major points.
Elements of the systematic review include: Background, Specific Aims (types of studies, population of interest, interventions, outcome measures), Methods (search strategy for identification of studies, how studies were selected how data were extracted and analyzed), Results (description of studies included, assessment of the quality of the studies, results of the analysis), Discussion and Conclusions (implications for practice and for research).
State of the Art Articles
This format is an authoritative synthesis of recent and past research with appropriate commentary and explanation to provide clinicians and investigators with an up-to-date account of the topic or field. Explanatory figures and diagrams are strongly encouraged, as are detailed tables research results.
Clinical Trial in Focus
This feature examines a previously published clinical trial in detail with focus on particular facets of the trial, such as elements that were not considered in the original publication, a new synthesis of substudies or comparisons to newer studies.
The trial is presented in detail including Introduction (background and rationale), Methods (subjects, eligibility, interventions, hypotheses, outcome measures, sample size, estimated power, interim analyses, stopping rules, randomization methods, approach to blinding and evaluation of success and statistical methods), Results (diagram of flow of participants from screening to final disposition, dates of recruitment and follow-up, baseline data, absolute numbers of participants in each group, summary of results for each group and details of all adverse effects), Discussion (interpretation of the results in terms of the hypotheses, limitations, generalizability of findings, clinical implications, questions answered, questions raised and unanswered questions).
Technical Report
This format provides detailed explanation and technical specifications of clinical or experimental methods, techniques, devices or diagnostic tests directed toward clinicians or investigators. Figures such as photographs and diagrams are strongly encouraged.
Editorial Commentary
This is flexible format that may address clinical, experimental, economic, policy or social issues. It may consist of a scholarly review that cannot be considered a Systematic Review or State of the Art report because the strict criteria are not met or because the authors are advocating a controversial or speculative position. Two reviews supporting opposite sides in a controversy may be published as Commentaries.
News and Views
These are brief reports or opinions that address noteworthy developments in the field of cardiac electrophysiology. This may include announcements, comments and critiques about research results, clinical practice or economic or regulator.
Letters to the Editor
The Journal of Interventional Cardiac Electrophysiology no longer accepts Letters to the Editor for publication. If you would like to reformat your letter as a brief commentary, we will consider posting it on the Journal’s Facebook page. The Facebook page is an open forum to prompt discussion and attract new readership to articles published in the Journal of Interventional Cardiac Electrophysiology. Facebook Commentary submissions are for Social Media purposes only and will not be covered by indexing services. Facebook commentaries should be 200 words maximum (most important statement should be in the first 2-3 sentences), with no references, figures or tables, and must not contain any data that would need citation. For consideration, please email your Facebook Commentary directly to the Publishing Editor. Do not submit Facebook Commentaries through Editorial Manager. In the body of the email, please provide the manuscript number of your original submission and the name of the article to which your Facebook Commentary refers.
Multicenter Clinical Trials
The Journal will preferentially consider multicenter clinical trials that have been registered with the geographically relevant governmental oversight body or site (e.g. in the USA http://www.clinicaltrials.gov). All mulitcenter clinical trials need registration for consideration for publication in the Journal. The cover letter accompanying the article should indicate the registration status. The Journal requires clinical trials to address outcome difference by gender, if this is applicable, in the results section.
Case Reports
Case Reports will only be considered for review if they comply with all of the following criteria: Content must be novel and not previously documented, and must have importance and relevance to current clinical practices. Case Reports cannot exceed one printed page in length including figures and references, and must be accompanied by a cover letter indicating their unique nature. Guidance would be either 350 words, or 175 words and up to two figures. References are limited to three. Abstracts are not necessary. Due to limited journal space, educational or discussion style teaching Case Reports will not be considered.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide a structured abstract of 150 to 250 words which should be divided into the following sections:
Purpose (stating the main purposes and research question)
Methods
Results
Conclusion
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
No abbreviations or symbols are permitted in the title. Title length should also be limited to a maximum of 24 words or 300 characters. Please include a short running title.
Text
Text Formatting
Manuscripts should be submitted in Word.
Use a normal, plain font (e.g., 10-point Times Roman) for text.
Use italics for emphasis.
Use the automatic page numbering function to number the pages.
Do not use field functions.
Use tab stops or other commands for indents, not the space bar.
Use the table function, not spreadsheets, to make tables.
Use the equation editor or MathType for equations.
Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Manuscripts with mathematical content can also be submitted in LaTeX.
LaTeX macro package (Download zip, 190 kB)
Headings
Please use the decimal system of headings with no more than three levels.
Abbreviations
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.
Scientific style
Please always use internationally accepted signs and symbols for units (SI units).
Nomenclature: Insofar as possible, authors should use systematic names similar to those used by Chemical Abstract Service or IUPAC.
Genus and species names should be in italics.
Generic names of drugs and pesticides are preferred; if trade names are used, the generic name should be given at first mention.
Please use the standard mathematical notation for formulae, symbols, etc.:Italic for single letters that denote mathematical constants, variables, and unknown quantities Roman/upright for numerals, operators, and punctuation, and commonly defined functions or abbreviations, e.g., cos, det, e or exp, lim, log, max, min, sin, tan, d (for derivative) Bold for vectors, tensors, and matrices.
References
Citation
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].
Reference list
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.
The entries in the list should be numbered consecutively.
If available, please always include DOIs as full DOI links in your reference list (e.g. “https://doi.org/abc”).
Journal article
Smith JJ. The world of science. Am J Sci. 1999;36:234–5.
Article by DOI
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. J Mol Med. 2000; https://doi.org/10.1007/s001090000086
Book
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.
Book chapter
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. pp. 251–306.
Online document
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
ISSN.org LTWA
If you are unsure, please use the full journal title.
Tables
All tables are to be numbered using Arabic numerals.
Tables should always be cited in text in consecutive numerical order.
For each table, please supply a table caption (title) explaining the components of the table.
Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.